TABLE 1.

Experimental cell treatment systems

Treatment conditions	0–72 h	72–144 h
Untreated control
TGF-β1	10 ng/ml TGF-β1	10 ng/ml TGF-β1
BMP7	400 ng/ml BMP7	400 ng/ml BMP7
Prevention I	10 ng/ml TGF-β1 and 400 ng/ml BMP7	10 ng/ml TGF-β1 and 400 ng/ml BMP7
Prevention II	400 ng/ml BMP7	10 ng/ml TGF-β1
Reversal	10 ng/ml TGF-β1	400 ng/ml BMP7